Skip to main navigation

Overview
News & Events
- Press Releases
- Events
Corporate Governance
Financial Information
- SEC Filings
Stock Information
- Stock Quote & Chart
- Analyst Coverage
IR Resources

Event Details

Key Opinion Leader Discussion on Onvansertib's Promising Single-Agent Activity

April 30, 2026 11:00 AM EDT

Contact Investor Relations

drafts IR@cardiffoncology.com

Subscribe to our Email Alerts

© Cardiff Oncology, Inc. All rights reserved.

Social Media

LinkedIn opens in new window

Search Investors

Search this site